Federal health officials are quietly moving to overhaul the fine print on testosterone replacement therapy, a shift that ...

Outside of her job as the therapist on the series “Couples Therapy,” she has a favorite clip of the rapper performing and ...

An enhanced telehealth model demonstrates feasibility and high clinician and patient acceptability for prostate cancer management.

In the United States, prostate cancer is a leading cause of cancer-related disease and death in men. About half of prostate ...

NeoGenomics, Inc.(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of PTEN IHC CDx, the first immunohistochemistry (IHC) ...

GE HealthCare GEHC has announced a new research collaboration with Mayo Clinic to advance personalized cancer treatment ...

The partnership will evaluate whether imaging- and biomarker-informed insights can support a more personalised approach to ...

Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...

ROCHESTER — Mayo Clinic and GE HealthCare will conduct research on an emerging treatment for prostate cancer and how that treatment can become more personalized to each patient, the two ...

HONG KONG, July 7, 2026 /PRNewswire/ -- The HKSH Cancer Centre under HKSH Medical Group (HKSH) introduced proton therapy in 2023, covering a wide range of cancer types including breast, prostate as ...

Scientists at the University of Illinois Chicago have turned an unlikely source into a potential new weapon against cancer: ...

Researchers found that one in three men had minimal symptomatic benefits from tamsulosin, the most commonly prescribed medication for older men with a form of urinary tract infections, and suggest ...